Year: 2022
Type: dissertation
Abstract: Photodynamic therapy (PDT) utilizes sensitizers, such as porphyrin, and light to locally generate cytotoxic reactive oxygen species (ROS) to treat tumors. The accumulation of sensitizers in the tumor is critical for effective ROS generation. Porphyrin liposomes (porphysomes) have been demonstrated to be an effective and passive accumulation platform for PDT but cannot be used for active delivery. Porphyrin microbubbles are capable of active delivery with ultrasound for subsequent PDT but are too large and short-lived for passive delivery. In this thesis, phase-change porphyrin droplets (AKA porphylets) are investigated as an agent that can bridge porphysomes and porphyrin microbubbles. Like porphysomes, porphylets can passively accumulate in tumors due to their stability and small diameters. Like porphyrin microbubbles, porphylets can respond to ultrasound for active delivery. Such an agent can be utilized as a multi-modal, multi-functional "one-for-all" platform that is capable of therapy and delivery quantification without the need for companion diagnostic agents.
Source: TSpace (University of Toronto)
Author: Yoo, Kimoon
Institution: University of Toronto
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7133080422
